Source:http://linkedlifedata.com/resource/pubmed/id/18355002
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-3-21
|
pubmed:abstractText |
Multiprotein complexes figure prominently in all cellular processes. Disrupting formation of these complexes can modulate key cellular pathways and offers new possibilities for therapeutic intervention. A new study illustrates an efficient approach for developing high-affinity mimics that inhibit protein-protein interactions.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1554-8937
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
20
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
140-1
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
Disrupting proteins to treat cancer.
|
pubmed:affiliation |
Department of Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, 750 East Adams Street, Syracuse, New York 13210, USA. lohs@upstate.edu
|
pubmed:publicationType |
Journal Article
|